Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Fierce Health vs Rivo Health

Fierce Health
Graded #410

Lower grade

vs+15.100000000000001
Rivo Health
Graded #90

Higher grade

The verdict

Rivo Health takes it — 71.7/100 to 56.6/100.

Rivo Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Rivo Health is a large nationwide GLP-1 telehealth program (115,000+ members, Trustpilot 4.7) offering compounded semaglutide and tirzepatide as both injections and oral options, starting around $149/mo for…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueRivo Health +41
33
74
Dose & formulationFierce Health +2
77
75
Clinical oversightRivo Health +15
62
77
Labs & monitoringRivo Health +11
52
63
FulfillmentRivo Health +9
75
84
Contract termsFierce Health +6
47
41
Fierce Health · left barRivo Health · right bar

The numbers

MetricFierce HealthRivo Health
WeighScore56.6/10071.7/100
GradeCC
Scorecard rank#410#90
Semaglutide$297/mo (3-month plan, compounded)$149/mo (compounded)
Tirzepatide$497/mo (3-month plan, compounded)$199/mo (compounded)
Coverage30 statesAll 50 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyYes
Fierce Health

Graded #410 · C

Strengths

  • 30-state service list spelled out in the Terms — buyers can verify eligibility before intake
  • LegitScript Certified
  • Publishes the FDA compounded-medication disclaimer on every product page
  • Four GLP-1 programs (standard and microdose semaglutide and tirzepatide) — a broader ladder than peers
  • Microdose tier at $197/mo is one of the lower entry points we've seen

Where it loses points

  • No named 503A compounding pharmacy partner — only generic 'partner pharmacies' language
  • Operating LLC name not disclosed anywhere on the site
  • Tirzepatide weight-loss program ($497/mo) showing 'sold out or unavailable' across all plans at review time
  • Clinical provider network not named
  • FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database
Rivo Health

Graded #90 · C

Strengths

  • Compounded semaglutide and tirzepatide as both injections and oral options, starting around $149/mo (sema) and $199/mo (tirz)
  • Bundles dietitians, live workouts, support groups and mental-health coaching with the medication, not just a prescription
  • Insurance concierge to maximize coverage, FSA/HSA eligible, with multi-month plans that cut the price further
  • Large, established program (115,000+ members, Trustpilot 4.7) available nationwide

Where it loses points

  • Uses partner compounding pharmacies it doesn't name on the site
  • Headline prices are Spring-sale rates — everyday cost is higher and the deepest discounts need a 6-month commitment
  • Weight loss is one of several verticals (ED, longevity, sleep, hair, skin), not a single focus
  • Some bundled perks (e.g. meal prep) are paid add-ons rather than included

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard